Research on clinical significance of CD3+ CD 56+ NKT cells and CD3- CD 56+ NK cells in patients with malignant tumors

Chinese Journal of Lung Cancer

Volumn 10, Issue 5, 2007, Pages 429-432

  Feng, Weihua ^a   Cai, Bei ^a   Wang, Lanlan ^a   Chen, Jie ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CD 3+ CD56+ NKT lymphocytes; CD 3 CD56+ NK lymphocytes; CD3+ CD8+ T lymphocytes; Malignant tumor

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL T CELL LYMPHOMA; SOLID TUMOR; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

EID: 35948977711     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Linn YC, Hui KM. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma,2003,44(9):1457-1462.
2. + NKT cells in peripheral blood of patients with B-cell non-Hodgkm's lymphoma. Chin J Cancer,2004,23(11Suppl):1437-1442.
3. Cao JP, Jiang ZM, Zhang XC, et al. The proliferation, phenotype change and anti-tumor activity of cytokine induced killer cells. Chin J Cell Mol Immunol,2005,2 (5):583-586.
4. Chan JK, Hamilton CA, Cheung MK, et al. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res,2006,12(6):1859- 1867.
5. + killer cells. Blood,1995,86(9):3493-3499.
6. + immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene. Gene Ther,1998,5(1):31-39.
7. Schmidt-Wolf IG, Finke S, Trojaneck B, et al. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma. Br J Cancer,1999,81(6):1009-1016.
8. Cen XN, Zhu P, Shi YJ, et al. Cytokine-induced killer cells induce apoptosis of K562 cells expressed bcr-abl. J Exper Hematol,2002,10(3):201-204.
9. Linn YC, Lau LC, Hui KM. Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts. Br J Haematol,2002,116(1):78-86.
10. + T cell in the peripheral blood on patients with malignant tumor. Immunol J,2001,17(1):47-49.
11. Wang FS, Liu MX, Zhang B, et al. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo. World J Gastroenterol,2002,8(3):464-468.
12. Chen FX, Liu JQ, Zhang NZ, et al. Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor. Chin J Cancer,2002,21(7):797-801.
13. Jiang J, Xu N, Wu C, et al. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res,2006,26(3B):2237-2242.
14. Yang XJ, Huang JA, Lei W, et al. Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo. Chin J Cancer,2006,25(11):1329-1333.